nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—SCN10A—melanoma	0.702	1	CbGaD
Orphenadrine—CYP2E1—Dacarbazine—melanoma	0.0486	0.444	CbGbCtD
Orphenadrine—CYP3A4—Temozolomide—melanoma	0.0351	0.32	CbGbCtD
Orphenadrine—CYP3A4—Vemurafenib—melanoma	0.0192	0.175	CbGbCtD
Orphenadrine—CYP3A4—Docetaxel—melanoma	0.0066	0.0602	CbGbCtD
Orphenadrine—Aplastic anaemia—Dactinomycin—melanoma	0.000364	0.0408	CcSEcCtD
Orphenadrine—Aplastic anaemia—Temozolomide—melanoma	0.000329	0.0369	CcSEcCtD
Orphenadrine—Anaphylactic shock—Vemurafenib—melanoma	0.000245	0.0274	CcSEcCtD
Orphenadrine—Skin disorder—Vemurafenib—melanoma	0.000238	0.0266	CcSEcCtD
Orphenadrine—Constipation—Vemurafenib—melanoma	0.000209	0.0235	CcSEcCtD
Orphenadrine—Hallucination—Carmustine—melanoma	0.000181	0.0203	CcSEcCtD
Orphenadrine—Tamoxifen—CYP1B1—melanoma	0.000181	0.117	CrCbGaD
Orphenadrine—Hypersensitivity—Vemurafenib—melanoma	0.00018	0.0202	CcSEcCtD
Orphenadrine—Asthenia—Vemurafenib—melanoma	0.000176	0.0197	CcSEcCtD
Orphenadrine—Hallucination—Temozolomide—melanoma	0.000175	0.0196	CcSEcCtD
Orphenadrine—Pruritus—Vemurafenib—melanoma	0.000173	0.0194	CcSEcCtD
Orphenadrine—Reboxetine—ABCB1—melanoma	0.000164	0.106	CrCbGaD
Orphenadrine—Dizziness—Vemurafenib—melanoma	0.000162	0.0181	CcSEcCtD
Orphenadrine—Vomiting—Vemurafenib—melanoma	0.000156	0.0174	CcSEcCtD
Orphenadrine—Headache—Vemurafenib—melanoma	0.000153	0.0172	CcSEcCtD
Orphenadrine—Confusional state—Bleomycin—melanoma	0.000149	0.0168	CcSEcCtD
Orphenadrine—Vision blurred—Carmustine—melanoma	0.000149	0.0167	CcSEcCtD
Orphenadrine—Tremor—Carmustine—melanoma	0.000149	0.0167	CcSEcCtD
Orphenadrine—Anaphylactic shock—Bleomycin—melanoma	0.000148	0.0166	CcSEcCtD
Orphenadrine—Agitation—Carmustine—melanoma	0.000146	0.0163	CcSEcCtD
Orphenadrine—Nausea—Vemurafenib—melanoma	0.000145	0.0163	CcSEcCtD
Orphenadrine—Vision blurred—Temozolomide—melanoma	0.000144	0.0162	CcSEcCtD
Orphenadrine—Fenoprofen—PTGS2—melanoma	0.000144	0.0929	CrCbGaD
Orphenadrine—Tremor—Temozolomide—melanoma	0.000144	0.0161	CcSEcCtD
Orphenadrine—Agitation—Temozolomide—melanoma	0.000141	0.0158	CcSEcCtD
Orphenadrine—Palpitations—Temozolomide—melanoma	0.000135	0.0152	CcSEcCtD
Orphenadrine—Confusional state—Carmustine—melanoma	0.00013	0.0146	CcSEcCtD
Orphenadrine—Toremifene—ABCB1—melanoma	0.00013	0.0838	CrCbGaD
Orphenadrine—Fenoprofen—ALB—melanoma	0.000129	0.0828	CrCbGaD
Orphenadrine—Tachycardia—Carmustine—melanoma	0.000126	0.0142	CcSEcCtD
Orphenadrine—Confusional state—Temozolomide—melanoma	0.000126	0.0141	CcSEcCtD
Orphenadrine—Anaphylactic shock—Temozolomide—melanoma	0.000125	0.014	CcSEcCtD
Orphenadrine—Feeling abnormal—Bleomycin—melanoma	0.000122	0.0137	CcSEcCtD
Orphenadrine—Skin disorder—Temozolomide—melanoma	0.000121	0.0136	CcSEcCtD
Orphenadrine—Urticaria—Bleomycin—melanoma	0.000118	0.0132	CcSEcCtD
Orphenadrine—Somnolence—Carmustine—melanoma	0.000115	0.0129	CcSEcCtD
Orphenadrine—Feeling abnormal—Dactinomycin—melanoma	0.000114	0.0128	CcSEcCtD
Orphenadrine—Somnolence—Temozolomide—melanoma	0.000111	0.0125	CcSEcCtD
Orphenadrine—Phenprocoumon—ALB—melanoma	0.000111	0.0714	CrCbGaD
Orphenadrine—Constipation—Carmustine—melanoma	0.000111	0.0124	CcSEcCtD
Orphenadrine—Hypersensitivity—Bleomycin—melanoma	0.000109	0.0122	CcSEcCtD
Orphenadrine—Fluoxetine—ALB—melanoma	0.000108	0.0694	CrCbGaD
Orphenadrine—Constipation—Temozolomide—melanoma	0.000107	0.012	CcSEcCtD
Orphenadrine—Feeling abnormal—Carmustine—melanoma	0.000107	0.012	CcSEcCtD
Orphenadrine—Asthenia—Bleomycin—melanoma	0.000106	0.0119	CcSEcCtD
Orphenadrine—Pruritus—Bleomycin—melanoma	0.000105	0.0118	CcSEcCtD
Orphenadrine—Feeling abnormal—Temozolomide—melanoma	0.000103	0.0116	CcSEcCtD
Orphenadrine—Fluoxetine—ABCB1—melanoma	0.000103	0.0663	CrCbGaD
Orphenadrine—Hypersensitivity—Dactinomycin—melanoma	0.000102	0.0114	CcSEcCtD
Orphenadrine—Urticaria—Temozolomide—melanoma	9.93e-05	0.0111	CcSEcCtD
Orphenadrine—Asthenia—Dactinomycin—melanoma	9.92e-05	0.0111	CcSEcCtD
Orphenadrine—Warfarin—ALB—melanoma	9.83e-05	0.0633	CrCbGaD
Orphenadrine—Hypersensitivity—Carmustine—melanoma	9.53e-05	0.0107	CcSEcCtD
Orphenadrine—Vomiting—Bleomycin—melanoma	9.42e-05	0.0106	CcSEcCtD
Orphenadrine—Asthenia—Carmustine—melanoma	9.28e-05	0.0104	CcSEcCtD
Orphenadrine—Hypersensitivity—Temozolomide—melanoma	9.21e-05	0.0103	CcSEcCtD
Orphenadrine—Palpitations—Docetaxel—melanoma	9e-05	0.0101	CcSEcCtD
Orphenadrine—Asthenia—Temozolomide—melanoma	8.97e-05	0.0101	CcSEcCtD
Orphenadrine—Pruritus—Temozolomide—melanoma	8.85e-05	0.00992	CcSEcCtD
Orphenadrine—Nausea—Bleomycin—melanoma	8.8e-05	0.00987	CcSEcCtD
Orphenadrine—Vomiting—Dactinomycin—melanoma	8.79e-05	0.00985	CcSEcCtD
Orphenadrine—Dizziness—Carmustine—melanoma	8.56e-05	0.00959	CcSEcCtD
Orphenadrine—Confusional state—Docetaxel—melanoma	8.38e-05	0.0094	CcSEcCtD
Orphenadrine—Anaphylactic shock—Docetaxel—melanoma	8.31e-05	0.00932	CcSEcCtD
Orphenadrine—Dizziness—Temozolomide—melanoma	8.27e-05	0.00927	CcSEcCtD
Orphenadrine—Vomiting—Carmustine—melanoma	8.23e-05	0.00922	CcSEcCtD
Orphenadrine—Nausea—Dactinomycin—melanoma	8.21e-05	0.00921	CcSEcCtD
Orphenadrine—Tachycardia—Docetaxel—melanoma	8.11e-05	0.0091	CcSEcCtD
Orphenadrine—Headache—Carmustine—melanoma	8.11e-05	0.00909	CcSEcCtD
Orphenadrine—Skin disorder—Docetaxel—melanoma	8.08e-05	0.00905	CcSEcCtD
Orphenadrine—Vomiting—Temozolomide—melanoma	7.95e-05	0.00891	CcSEcCtD
Orphenadrine—Headache—Temozolomide—melanoma	7.83e-05	0.00878	CcSEcCtD
Orphenadrine—Nausea—Carmustine—melanoma	7.68e-05	0.00862	CcSEcCtD
Orphenadrine—Nausea—Temozolomide—melanoma	7.43e-05	0.00833	CcSEcCtD
Orphenadrine—Somnolence—Docetaxel—melanoma	7.39e-05	0.00829	CcSEcCtD
Orphenadrine—Constipation—Docetaxel—melanoma	7.11e-05	0.00797	CcSEcCtD
Orphenadrine—Feeling abnormal—Docetaxel—melanoma	6.85e-05	0.00768	CcSEcCtD
Orphenadrine—Hypersensitivity—Docetaxel—melanoma	6.13e-05	0.00687	CcSEcCtD
Orphenadrine—Asthenia—Docetaxel—melanoma	5.97e-05	0.00669	CcSEcCtD
Orphenadrine—Pruritus—Docetaxel—melanoma	5.88e-05	0.00659	CcSEcCtD
Orphenadrine—Dizziness—Docetaxel—melanoma	5.5e-05	0.00616	CcSEcCtD
Orphenadrine—Trimipramine—ABCB1—melanoma	5.44e-05	0.035	CrCbGaD
Orphenadrine—Vomiting—Docetaxel—melanoma	5.29e-05	0.00593	CcSEcCtD
Orphenadrine—Promethazine—ABCB1—melanoma	5.24e-05	0.0337	CrCbGaD
Orphenadrine—Headache—Docetaxel—melanoma	5.21e-05	0.00584	CcSEcCtD
Orphenadrine—Tamoxifen—ABCB1—melanoma	5.2e-05	0.0335	CrCbGaD
Orphenadrine—Doxepin—ABCB1—melanoma	5.18e-05	0.0334	CrCbGaD
Orphenadrine—Methadone—ABCB1—melanoma	5.15e-05	0.0332	CrCbGaD
Orphenadrine—Nausea—Docetaxel—melanoma	4.94e-05	0.00554	CcSEcCtD
Orphenadrine—Amitriptyline—ALB—melanoma	4.2e-05	0.027	CrCbGaD
Orphenadrine—Imipramine—ABCB1—melanoma	4.03e-05	0.026	CrCbGaD
Orphenadrine—Amitriptyline—ABCB1—melanoma	4.01e-05	0.0258	CrCbGaD
Orphenadrine—CHRM2—Signaling Pathways—EDNRB—melanoma	1.17e-05	6.54e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLCB4—melanoma	1.16e-05	6.53e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTK2B—melanoma	1.15e-05	6.45e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GNA11—melanoma	1.14e-05	6.42e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTK2B—melanoma	1.13e-05	6.35e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GNA11—melanoma	1.12e-05	6.29e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—FASN—melanoma	1.12e-05	6.28e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GNA11—melanoma	1.12e-05	6.28e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GAB2—melanoma	1.12e-05	6.28e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FLT1—melanoma	1.11e-05	6.25e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CG—melanoma	1.1e-05	6.19e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SLC5A5—melanoma	1.1e-05	6.18e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GNA11—melanoma	1.1e-05	6.18e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GAB2—melanoma	1.1e-05	6.18e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—FASN—melanoma	1.1e-05	6.15e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FLT1—melanoma	1.1e-05	6.15e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC6A11—melanoma	1.1e-05	6.14e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.1e-05	6.14e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CG—melanoma	1.09e-05	6.09e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SLC5A5—melanoma	1.08e-05	6.05e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTAP—melanoma	1.07e-05	5.97e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GNAQ—melanoma	1.06e-05	5.97e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CD44—melanoma	1.06e-05	5.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HDAC2—melanoma	1.05e-05	5.9e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FOXO4—melanoma	1.05e-05	5.9e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCR4—melanoma	1.05e-05	5.9e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GNAQ—melanoma	1.04e-05	5.84e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CD44—melanoma	1.04e-05	5.84e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GNAQ—melanoma	1.04e-05	5.84e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FOXO4—melanoma	1.04e-05	5.81e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HDAC2—melanoma	1.04e-05	5.81e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCR4—melanoma	1.04e-05	5.81e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GNAQ—melanoma	1.02e-05	5.74e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP1B1—melanoma	1.02e-05	5.72e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CG—melanoma	1e-05	5.62e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP1B1—melanoma	9.99e-06	5.6e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CG—melanoma	9.87e-06	5.53e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SYK—melanoma	9.79e-06	5.49e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CD—melanoma	9.71e-06	5.44e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SYK—melanoma	9.63e-06	5.4e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT3—melanoma	9.61e-06	5.39e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NGFR—melanoma	9.61e-06	5.39e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ITGAV—melanoma	9.61e-06	5.39e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CD—melanoma	9.55e-06	5.36e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PHGDH—melanoma	9.49e-06	5.32e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LUM—melanoma	9.49e-06	5.32e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NGFR—melanoma	9.45e-06	5.3e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT3—melanoma	9.45e-06	5.3e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ITGAV—melanoma	9.45e-06	5.3e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HPSE—melanoma	9.31e-06	5.22e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CUBN—melanoma	9.14e-06	5.12e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SOCS1—melanoma	8.9e-06	4.99e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAP2K1—melanoma	8.88e-06	4.98e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—S100B—melanoma	8.87e-06	4.98e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SDHD—melanoma	8.83e-06	4.95e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—BSG—melanoma	8.83e-06	4.95e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CSPG4—melanoma	8.83e-06	4.95e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CD—melanoma	8.82e-06	4.94e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SOCS1—melanoma	8.75e-06	4.91e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAP2K1—melanoma	8.73e-06	4.9e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—S100B—melanoma	8.73e-06	4.9e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CD—melanoma	8.68e-06	4.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPAM—melanoma	8.55e-06	4.79e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB4—melanoma	8.49e-06	4.76e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CB—melanoma	8.46e-06	4.75e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN2B—melanoma	8.41e-06	4.72e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ABCB1—melanoma	8.4e-06	4.71e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB4—melanoma	8.35e-06	4.68e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CB—melanoma	8.33e-06	4.67e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN2B—melanoma	8.28e-06	4.64e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ABCB1—melanoma	8.23e-06	4.61e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CD86—melanoma	8.14e-06	4.56e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL8—melanoma	8.13e-06	4.56e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EDN1—melanoma	8.07e-06	4.53e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CD86—melanoma	8.01e-06	4.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL8—melanoma	8e-06	4.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EDN1—melanoma	7.94e-06	4.45e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGF1—melanoma	7.89e-06	4.42e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CSF2—melanoma	7.89e-06	4.42e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—IL2—melanoma	7.77e-06	4.36e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGF1—melanoma	7.76e-06	4.35e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CSF2—melanoma	7.76e-06	4.35e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PRKCA—melanoma	7.73e-06	4.34e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—E2F1—melanoma	7.72e-06	4.33e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CB—melanoma	7.69e-06	4.31e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ERCC2—melanoma	7.67e-06	4.3e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—IL2—melanoma	7.65e-06	4.29e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PDGFRA—melanoma	7.64e-06	4.28e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—E2F1—melanoma	7.6e-06	4.26e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PRKCA—melanoma	7.57e-06	4.25e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PRKCA—melanoma	7.56e-06	4.24e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ITGB3—melanoma	7.56e-06	4.24e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CB—melanoma	7.56e-06	4.24e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PDGFRA—melanoma	7.52e-06	4.22e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ERCC2—melanoma	7.51e-06	4.21e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PRKCA—melanoma	7.44e-06	4.17e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ITGB3—melanoma	7.44e-06	4.17e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SPP1—melanoma	7.42e-06	4.16e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAP2K2—melanoma	7.39e-06	4.15e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL8—melanoma	7.39e-06	4.14e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SPP1—melanoma	7.3e-06	4.09e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAP2K2—melanoma	7.28e-06	4.08e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLA2G6—melanoma	7.27e-06	4.08e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL8—melanoma	7.27e-06	4.07e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL2—melanoma	7.06e-06	3.96e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TERT—melanoma	7.03e-06	3.94e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RAC1—melanoma	7.01e-06	3.93e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL2—melanoma	6.94e-06	3.89e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TERT—melanoma	6.92e-06	3.88e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RAC1—melanoma	6.9e-06	3.87e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HIF1A—melanoma	6.73e-06	3.77e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HIF1A—melanoma	6.62e-06	3.71e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—VCAN—melanoma	6.53e-06	3.66e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KDR—melanoma	6.43e-06	3.61e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KDR—melanoma	6.33e-06	3.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FN1—melanoma	6.19e-06	3.47e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FN1—melanoma	6.09e-06	3.42e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOTCH1—melanoma	6.06e-06	3.4e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CG—melanoma	6.06e-06	3.4e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOTCH1—melanoma	5.96e-06	3.34e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CD80—melanoma	5.94e-06	3.33e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CG—melanoma	5.93e-06	3.33e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CG—melanoma	5.92e-06	3.32e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APC—melanoma	5.92e-06	3.32e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KIT—melanoma	5.92e-06	3.32e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—NRAS—melanoma	5.92e-06	3.32e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGF—melanoma	5.86e-06	3.28e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARG—melanoma	5.85e-06	3.28e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CD80—melanoma	5.84e-06	3.27e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CG—melanoma	5.83e-06	3.27e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KIT—melanoma	5.83e-06	3.27e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APC—melanoma	5.83e-06	3.27e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—NRAS—melanoma	5.83e-06	3.27e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGF—melanoma	5.76e-06	3.23e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARG—melanoma	5.73e-06	3.21e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK3—melanoma	5.67e-06	3.18e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK3—melanoma	5.58e-06	3.13e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—BRAF—melanoma	5.57e-06	3.12e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP17A1—melanoma	5.51e-06	3.09e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—BRAF—melanoma	5.48e-06	3.07e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1—melanoma	5.42e-06	3.04e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK1—melanoma	5.4e-06	3.03e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EGFR—melanoma	5.4e-06	3.03e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1—melanoma	5.34e-06	2.99e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CD—melanoma	5.32e-06	2.99e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK1—melanoma	5.31e-06	2.98e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EGFR—melanoma	5.31e-06	2.98e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALB—melanoma	5.26e-06	2.95e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAP2K1—melanoma	5.24e-06	2.94e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CD—melanoma	5.22e-06	2.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CD—melanoma	5.21e-06	2.92e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GNA11—melanoma	5.2e-06	2.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CA—melanoma	5.16e-06	2.89e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAP2K1—melanoma	5.16e-06	2.89e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALB—melanoma	5.15e-06	2.89e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CD—melanoma	5.13e-06	2.87e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—KRAS—melanoma	5.1e-06	2.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—FASN—melanoma	5.09e-06	2.85e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	5.08e-06	2.85e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—KRAS—melanoma	5.02e-06	2.81e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC5A5—melanoma	5.01e-06	2.81e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGF2—melanoma	4.99e-06	2.8e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGF2—melanoma	4.91e-06	2.75e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GNAQ—melanoma	4.84e-06	2.71e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CD44—melanoma	4.84e-06	2.71e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CA—melanoma	4.68e-06	2.63e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MDM2—melanoma	4.67e-06	2.62e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CB—melanoma	4.64e-06	2.6e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP1B1—melanoma	4.64e-06	2.6e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CA—melanoma	4.61e-06	2.58e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB2—melanoma	4.6e-06	2.58e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—melanoma	4.6e-06	2.58e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MDM2—melanoma	4.59e-06	2.57e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CB—melanoma	4.55e-06	2.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CB—melanoma	4.54e-06	2.55e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB2—melanoma	4.53e-06	2.54e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—melanoma	4.5e-06	2.53e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CB—melanoma	4.47e-06	2.5e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL8—melanoma	4.36e-06	2.45e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HRAS—melanoma	4.33e-06	2.43e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL8—melanoma	4.29e-06	2.41e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HRAS—melanoma	4.27e-06	2.39e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN1B—melanoma	4.26e-06	2.39e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—melanoma	4.21e-06	2.36e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN1B—melanoma	4.19e-06	2.35e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP3—melanoma	4.18e-06	2.34e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL2—melanoma	4.17e-06	2.34e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—melanoma	4.15e-06	2.33e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—melanoma	4.15e-06	2.33e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP3—melanoma	4.11e-06	2.3e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL2—melanoma	4.1e-06	2.3e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—melanoma	4.08e-06	2.29e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCND1—melanoma	4.06e-06	2.28e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CTNNB1—melanoma	4.03e-06	2.26e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTEN—melanoma	4.01e-06	2.25e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCND1—melanoma	4e-06	2.24e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CTNNB1—melanoma	3.96e-06	2.22e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP9—melanoma	3.95e-06	2.21e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN1A—melanoma	3.93e-06	2.2e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTEN—melanoma	3.93e-06	2.2e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTEN—melanoma	3.92e-06	2.2e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NFKB1—melanoma	3.9e-06	2.19e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP9—melanoma	3.88e-06	2.18e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN1A—melanoma	3.87e-06	2.17e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTEN—melanoma	3.86e-06	2.16e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NFKB1—melanoma	3.84e-06	2.15e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—melanoma	3.83e-06	2.15e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCB1—melanoma	3.82e-06	2.14e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—melanoma	3.77e-06	2.11e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—melanoma	3.54e-06	1.99e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PRKCA—melanoma	3.51e-06	1.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT3—melanoma	3.51e-06	1.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NRAS—melanoma	3.5e-06	1.96e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—melanoma	3.49e-06	1.96e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ERCC2—melanoma	3.49e-06	1.95e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT3—melanoma	3.45e-06	1.94e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NRAS—melanoma	3.44e-06	1.93e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK3—melanoma	3.35e-06	1.88e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK3—melanoma	3.3e-06	1.85e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MYC—melanoma	3.26e-06	1.83e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MYC—melanoma	3.21e-06	1.8e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK1—melanoma	3.19e-06	1.79e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGFR—melanoma	3.19e-06	1.79e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK1—melanoma	3.14e-06	1.76e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGFR—melanoma	3.14e-06	1.76e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KRAS—melanoma	3.01e-06	1.69e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KRAS—melanoma	2.96e-06	1.66e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CA—melanoma	2.83e-06	1.59e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CA—melanoma	2.77e-06	1.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CA—melanoma	2.77e-06	1.55e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CG—melanoma	2.75e-06	1.54e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.72e-06	1.53e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—melanoma	2.68e-06	1.5e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARG—melanoma	2.66e-06	1.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—melanoma	2.63e-06	1.48e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HRAS—melanoma	2.56e-06	1.44e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HRAS—melanoma	2.52e-06	1.41e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—melanoma	2.45e-06	1.37e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CD—melanoma	2.42e-06	1.36e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—melanoma	2.41e-06	1.35e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALB—melanoma	2.39e-06	1.34e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—melanoma	2.31e-06	1.3e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—melanoma	2.26e-06	1.27e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—melanoma	2.26e-06	1.27e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—melanoma	2.22e-06	1.25e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CB—melanoma	2.11e-06	1.18e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—melanoma	2.09e-06	1.17e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTEN—melanoma	1.82e-06	1.02e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CA—melanoma	1.29e-06	7.21e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—melanoma	1.05e-06	5.89e-06	CbGpPWpGaD
